MedTrace Logo

Novel Coronavirus Induced Severe Pneumonia Treated by Dental Pulp Mesenchymal Stem Cells

NCT04302519 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2020-03-10

No results posted yet for this study

Summary

Evaluation of novel coronavirus induced severe pneumonia by dental pulp mesenchymal stem cells

Conditions

Interventions

BIOLOGICAL

Dental pulp mesenchymal stem cells

On the basis of clinical standard treatment, the injection of dental mesenchymal stem cells was increased on day 1, 3 and 7 of the trial.

Sponsors & Collaborators

  • CAR-T (Shanghai) Biotechnology Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Liwei cheng, doctor · Research office of wuhan renmin university

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-05
Primary Completion
2021-06-30
Completion
2021-07-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04302519 on ClinicalTrials.gov